News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
428,324 Results
Type
Article (23043)
Company Profile (144)
Press Release (405115)
Multimedia
Podcasts (122)
Webinars (20)
Section
Business (126863)
Career Advice (994)
Deals (23955)
Drug Delivery (120)
Drug Development (58595)
Employer Resources (90)
FDA (11919)
Job Trends (9458)
News (225083)
Policy (20939)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (959)
Accelerated approval (32)
Adcomms (23)
Allergies (117)
Alliances (31658)
ALS (129)
Alzheimer's disease (1083)
Antibody-drug conjugate (ADC) (278)
Approvals (12208)
Artificial intelligence (407)
Autoimmune disease (159)
Automation (24)
Bankruptcy (229)
Best Places to Work (7051)
BIOSECURE Act (15)
Biosimilars (185)
Biotechnology (63)
Bladder cancer (134)
Brain cancer (46)
Breast cancer (439)
Cancer (3540)
Cardiovascular disease (320)
Career advice (835)
Career pathing (29)
CAR-T (166)
CDC (22)
Cell therapy (450)
Cervical cancer (20)
Clinical research (51873)
Collaboration (1328)
Company closure (2)
Compensation (547)
Complete response letters (65)
COVID-19 (1511)
CRISPR (60)
C-suite (708)
Cystic fibrosis (103)
Data (5008)
Decentralized trials (3)
Denatured (28)
Depression (113)
Dermatology (44)
Diabetes (375)
Diagnostics (3365)
Digital health (25)
Diversity (9)
Diversity, equity & inclusion (24)
Drug discovery (214)
Drug pricing (215)
Drug shortages (34)
Duchenne muscular dystrophy (186)
Earnings (55461)
Editorial (51)
Employer branding (13)
Employer resources (88)
Events (63041)
Executive appointments (756)
FDA (14460)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (8)
Frontotemporal dementia (12)
Funding (899)
Gene editing (123)
Generative AI (39)
Gene therapy (373)
GLP-1 (917)
Government (2357)
Grass and pollen (4)
Guidances (334)
Healthcare (8607)
HIV (43)
Huntington's disease (31)
IgA nephropathy (71)
Immunology and inflammation (217)
Immuno-oncology (65)
Indications (129)
Infectious disease (1712)
Inflammatory bowel disease (158)
Inflation Reduction Act (12)
Influenza (76)
Intellectual property (216)
Interviews (139)
IPO (10480)
IRA (54)
Job creations (2644)
Job search strategy (723)
JPM (55)
Kidney cancer (13)
Labor market (66)
Layoffs (363)
Leadership (31)
Legal (4808)
Liver cancer (53)
Longevity (11)
Lung cancer (476)
Lymphoma (299)
Machine learning (30)
Management (35)
Manufacturing (686)
MASH (148)
Medical device (6025)
Medtech (6054)
Mergers & acquisitions (14343)
Metabolic disorders (1162)
mRNA (100)
Multiple sclerosis (130)
NASH (21)
Neurodegenerative disease (238)
Neuropsychiatric disorders (89)
Neuroscience (2087)
Neurotech (1)
NextGen: Class of 2026 (3089)
Non-profit (1180)
Now hiring (53)
Obesity (611)
Opinion (244)
Ovarian cancer (109)
Pain (198)
Pancreatic cancer (155)
Parkinson's disease (252)
Partnered (20)
Patents (437)
Patient recruitment (397)
Peanut (33)
People (38815)
Pharmaceutical (74)
Pharmacy benefit managers (36)
Phase 1 (16199)
Phase 2 (22288)
Phase 3 (17556)
Pipeline (5388)
Policy (252)
Postmarket research (1747)
Preclinical (5928)
Press Release (29)
Prostate cancer (197)
Psychedelics (34)
Radiopharmaceuticals (211)
Rare diseases (733)
Real estate (3544)
Recruiting (36)
Regulatory (17252)
Reports (28)
Research institute (1025)
Resumes & cover letters (157)
Rett syndrome (25)
RNA editing (14)
RSV (56)
Schizophrenia (151)
Series A (159)
Series B (107)
Service/supplier (8)
Sickle cell disease (80)
Special edition (23)
Spinal muscular atrophy (127)
Sponsored (23)
Startups (2228)
State (2)
Stomach cancer (13)
Supply chain (95)
Tariffs (95)
The Weekly (91)
Vaccines (554)
Venture capital (80)
Weight loss (440)
Women's health (69)
Worklife (10)
Date
Today (5)
Last 7 days (447)
Last 30 days (1869)
Last 365 days (20275)
2026 (5383)
2025 (20502)
2024 (23319)
2023 (25954)
2022 (32893)
2021 (33796)
2020 (31609)
2019 (24804)
2018 (19242)
2017 (21194)
2016 (19384)
2015 (23066)
2014 (17814)
2013 (14646)
2012 (15719)
2011 (16143)
2010 (14855)
Location
Africa (458)
Alabama (69)
Alaska (2)
Arizona (121)
Arkansas (10)
Asia (28357)
Australia (3901)
California (7595)
Canada (2190)
China (891)
Colorado (353)
Connecticut (336)
Delaware (253)
Europe (59924)
Florida (1291)
Georgia (235)
Hawaii (2)
Idaho (20)
Illinois (630)
India (70)
Indiana (414)
Iowa (5)
Japan (416)
Kansas (95)
Kentucky (34)
Louisiana (16)
Maine (50)
Maryland (982)
Massachusetts (5643)
Michigan (135)
Minnesota (399)
Mississippi (4)
Missouri (60)
Montana (21)
Nebraska (16)
Nevada (91)
New Hampshire (30)
New Jersey (2540)
New Mexico (21)
New York (2143)
North Carolina (1116)
North Dakota (3)
Northern California (3624)
Ohio (242)
Oklahoma (9)
Oregon (25)
Pennsylvania (1628)
Puerto Rico (24)
Rhode Island (33)
South America (666)
South Carolina (61)
Southern California (3172)
Tennessee (95)
Texas (1314)
United States (28290)
Utah (237)
Virginia (243)
Washington D.C. (64)
Washington State (611)
West Virginia (3)
Wisconsin (83)
Wyoming (1)
428,324 Results for "solasia pharma k k".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ValGenesis Strengthens Presence in Japan with Validator K.K. Partnership
April 1, 2026
·
3 min read
Drug pricing
UK Agrees To Boost Drug Spending by 25% To Avoid US Pharma Tariffs
U.K.-based pharmas will not face tariffs as long as Donald Trump is president, according to the agreement.
December 1, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Sakura Finetek Global and Hamamatsu Photonics K.K. Global Alliance Press Release
March 20, 2026
·
3 min read
Press Releases
Two Leaders in Pathology Innovation: Sakura Finetek and Hamamatsu Photonics K.K. Announce Global Alliance
March 20, 2026
·
3 min read
Press Releases
ORAGENICS FILES ANNUAL REPORT ON FORM 10-K
March 17, 2026
·
6 min read
Government
How the UK’s ‘Credibility Challenge’ Hinders Attempts To Reverse Pharma’s Flight
Talks between pharma and successive U.K. governments have failed to deliver the market access terms that the industry wants, contributing to a pullback in investment.
October 1, 2025
·
4 min read
·
Nick Paul Taylor
C-suite
GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years
Chief Commerical Officer Luke Miels will replace outgoing GSK CEO Emma Walmsley at the U.K. pharma next year.
September 29, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26
March 16, 2026
·
11 min read
Press Releases
OS Therapies Granted Meetings with U.S. FDA, U.K. MHRA, EMA and Australian Therapeutic Goods Administration to Review Global Confirmatory Phase 3 Trial for OST-HER2 in Metastatic Osteosarcoma
• Meetings with all four regulatory agencies scheduled to occur in the second quarter of 2026, with expected Phase 3 commencement in the third quarter of 2026 initially in Australia • Commencing the Phase 3 confirmatory study is a pre-requisite to being granted a Biologics License Application (BLA) under the Accelerated Approval Program in the U.S. and Conditional Marketing Authorisations (CMAs) in the U.K. & Europe
March 27, 2026
·
5 min read
Press Releases
BeyondSpring Files 2025 Annual Report on Form 10-K
March 26, 2026
·
2 min read
1 of 42,833
Next
